These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30596709)

  • 41. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of tulathromycin in healthy and neutropenic mice challenged intranasally with lipopolysaccharide from Escherichia coli.
    Villarino N; Brown SA; Martín-Jiménez T
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4078-86. PubMed ID: 22585224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a neutralizing mouse-pig chimeric antibody with therapeutic potential against Haemophilus parasuis in Pichia pastoris.
    Chai Z; Fu F; Jiang F; Tian H; Wang Z; Zheng N; Zhang X; Wang X; Li X
    FEMS Microbiol Lett; 2014 May; 354(2):85-91. PubMed ID: 24698098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of tulathromycin in edible tissues of healthy and experimentally infected pigs with Actinobacillus pleuropneumoniae.
    Bladek T; Posyniak A; Jablonski A; Gajda A
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(11):1823-32. PubMed ID: 26247868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative virulence of Haemophilus parasuis serovars 1 to 7 in guinea pigs.
    Rapp-Gabrielson VJ; Gabrielson DA; Schamber GJ
    Am J Vet Res; 1992 Jun; 53(6):987-94. PubMed ID: 1626790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Potter TJ; Pelligand L; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2017 Oct; 40(5):419-428. PubMed ID: 27891615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
    J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach.
    Lin Z; Cuneo M; Rowe JD; Li M; Tell LA; Allison S; Carlson J; Riviere JE; Gehring R
    BMC Vet Res; 2016 Nov; 12(1):258. PubMed ID: 27863483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A single laboratory-validated LC-MS method for the analysis of tulathromycin residues in bison and deer sera and selected tissues of white-tailed deer.
    Boison JO; Bachtold K; Matus J; Alcorn J; Woodbury M
    Drug Test Anal; 2016 May; 8(5-6):584-95. PubMed ID: 27443215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
    Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and tissue elimination of tulathromycin following subcutaneous administration in meat goats.
    Romanet J; Smith GW; Leavens TL; Baynes RE; Wetzlich SE; Riviere JE; Tell LA
    Am J Vet Res; 2012 Oct; 73(10):1634-40. PubMed ID: 23013191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial susceptibility of Haemophilus parasuis and Histophilus somni from pigs and cattle in Denmark.
    Aarestrup FM; Seyfarth AM; Angen Ø
    Vet Microbiol; 2004 Jun; 101(2):143-6. PubMed ID: 15172697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against
    Lei Z; Liu Q; Yang B; Ahmed S; Cao J; He Q
    Oncotarget; 2018 Jan; 9(2):1673-1690. PubMed ID: 29416722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antibacterial activity and action mechanism of emodin from Polygonum cuspidatum against Haemophilus parasuis in vitro.
    Li L; Song X; Yin Z; Jia R; Li Z; Zhou X; Zou Y; Li L; Yin L; Yue G; Ye G; Lv C; Shi W; Fu Y
    Microbiol Res; 2016; 186-187():139-45. PubMed ID: 27242151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing tylosin dosage for co-infection of
    Lee EB; Abbas MA; Park J; Tassew DD; Park SC
    Front Pharmacol; 2023; 14():1258403. PubMed ID: 37808183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caprine abscess model of tulathromycin concentrations in interstitial fluid from tissue chambers inoculated with Corynebacterium pseudotuberculosis following subcutaneous or intrachamber administration.
    Washburn KE; Fajt VR; Lawhon SD; Adams LG; Tell LA; Bissett WT
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6295-304. PubMed ID: 24100501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung.
    Gáler D; Hessong S; Beato B; Risk J; Inskeep P; Weerasinghe C; Schneider RP; Langer C; LaPerle J; Renouf D; Bessire A; Español E; Rafka R; Ragan C; Boettner W; Murphy T; Keller D; Benchaoui H; Nowakowski MA
    J Agric Food Chem; 2004 Apr; 52(8):2179-91. PubMed ID: 15080618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry.
    Scheuch E; Spieker J; Venner M; Siegmund W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):464-70. PubMed ID: 17267304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of tulathromycin in nonpregnant adult ewes.
    Washburn K; Fajt VR; Coetzee JF; Rice S; Wulf LW; Washburn S
    J Vet Pharmacol Ther; 2015 Aug; 38(4):414-6. PubMed ID: 25488837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.